Showing results (71-80 of 106) with videos related to
Sort By:
Pageof 11
Transplant International : Official Journal of the European Society for Organ Transplantation|March 25, 2018
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort studyTommaso M Manzia, Quirino Lai, Samuele Iesari, et al.European Journal of Gastroenterology & Hepatology|August 6, 2008
Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis CMario Angelico, Beate Koehler-Horst, Paola Piccolo, et al.Journal of Viral Hepatitis|April 12, 2019
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infectionRomina Salpini, Arianna Battisti, Luna Colagrossi, et al.Atherosclerosis|April 12, 2017
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort studyFrancesco Angelico, Stefano Ginanni Corradini, Daniele Pastori, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2021
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantationQuirino Lai, Paolo Magistri, Raffaella Lionetti, et al.BMC Infectious Diseases|May 18, 2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort studySimone Lanini, Paola Scognamiglio, Alessandra Mecozzi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2015
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practiceValeria Cento, Monica Tontodonati, Velia Chiara Di Maio, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2023
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver TransplantationPaolo Angelo Cortesi, Raffaella Viganò, Sara Conti, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2010
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemiaValentina Svicher, Claudia Alteri, Caterina Gori, et al.Journal of Viral Hepatitis|August 17, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosisChiara Masetti, Raffaella Lionetti, Marinella Lupo, et al.Pageof 11